Title
Genomic surveillance of the Lambda SARS-CoV-2 variant in a global phylogenetic context
Date Issued
01 October 2022
Access level
open access
Resource Type
journal article
Author(s)
Lizarraga W.
Hurtado V.
Molina I.S.
Barcena L.
Acedo S.
Nuñez A.
Gordillo S.
Sevilla N.
Medrano P.
Vargas-Herrera N.
Lope-Pari P.
Huayra J.
Publisher(s)
John Wiley and Sons Inc
Abstract
The massive sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and global genomic surveillance strategies allowed the detection of many variants of concern and interest. The variant of interest Lambda (C.37), which originated in South America, has been the most prevalent in Peru and Chile, but its dispersion in other continents still remains unknown. The current study aims to determine the phylogenetic relationship among C.37 isolates worldwide, focusing on spike mutations to understand the spread of Lambda in pandemics. A total of 7441 sequences identified as C.37 were downloaded from the GISAID database; local analysis was carried out to identify spike mutations and phylogenetic analysis was carried out to determine the rate of spread of the virus. Our results showed some spike mutations of Lambda that allowed us to detect small local outbreaks in different countries that occurred in the past and identify several clades that have not yet been designated. Although the lineage C.37 is not epidemiologically relevant in Europe or North America, the endemic behavior of this variant in Peru had a major impact on the second SARS-CoV-2 wave.
Start page
4689
End page
4695
Volume
94
Issue
10
Language
English
OCDE Knowledge area
Biotecnología relacionada con la salud
Epidemiología
Subjects
Scopus EID
2-s2.0-85131543487
PubMed ID
Source
Journal of Medical Virology
ISSN of the container
01466615
Sponsor(s)
We are grateful to the COVID-19 diagnostic team of the National Institute of Health in Peru, laboratory staff, and many international research groups of COVID-19 who have been contributing to this study by sharing genomic sequences in a free access database. This study was financially supported by the Genomic Surveillance Project of SARS-CoV-2 of the National Institute of Health in Peru.
We are grateful to the COVID‐19 diagnostic team of the National Institute of Health in Peru, laboratory staff, and many international research groups of COVID‐19 who have been contributing to this study by sharing genomic sequences in a free access database. This study was financially supported by the Genomic Surveillance Project of SARS‐CoV‐2 of the National Institute of Health in Peru.
Sources of information:
Directorio de Producción Científica
Scopus